Astellas Pharma Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	291,535	31,237	24,969	132,361	156,886
Depreciation & Amortization	194,594	199,132	157,840	105,738	79,684
Loss (Gain) From Sale of Assets	-	187,564	78,931	84,499	74,850
Asset Writedown & Restructuring Costs	54,187	-	-	-	-
Other Operating Activities	56,857	-75,674	-37,563	-68,811	-43,293
Change in Accounts Receivable	-63,794	-104,735	-55,948	-4,849	-8,001
Change in Inventory	-16,218	-50,225	-60,036	-7,086	24,058
Change in Accounts Payable	-307	-11,409	29,466	-12,274	-10,101
Change in Other Net Operating Assets	43,334	18,622	34,816	98,189	-16,639
Operating Cash Flow	560,188	194,512	172,475	327,767	257,444
Operating Cash Flow Growth	188.00%	12.78%	-47.38%	27.32%	-16.10%
Capital Expenditures	-57,723	-37,003	-38,056	-36,441	-30,739
Sale of Property, Plant & Equipment	-	-	-	-	441
Cash Acquisitions	-	-	-784,974	-	-670
Sale (Purchase) of Intangibles	-26,922	-19,168	-33,438	-51,888	-21,428
Investment in Securities	-	12,920	-	12,624	-
Other Investing Activities	17,923	-46,168	10,666	-8,795	-10,017
Investing Cash Flow	-66,722	-89,419	-845,802	-84,500	-62,413
Short-Term Debt Issued	-	-	324,337	-	-
Long-Term Debt Issued	-	200,000	472,275	50,000	-
Total Debt Issued	-	200,000	796,612	50,000	-
Short-Term Debt Repaid	-185,625	-236,449	-	-15,000	-
Long-Term Debt Repaid	-97,269	-52,073	-25,379	-50,000	-60,000
Total Debt Repaid	-282,894	-288,522	-25,379	-65,000	-60,000
Net Debt Issued (Repaid)	-282,894	-88,522	771,233	-15,000	-60,000
Repurchase of Common Stock	-730	-6,960	-10,735	-60,556	-50,717
Common Dividends Paid	-136,099	-128,993	-116,653	-100,355	-85,236
Other Financing Activities	14,944	-36,892	-29,785	-19,712	-20,345
Financing Cash Flow	-404,779	-261,367	614,060	-195,623	-216,298
Foreign Exchange Rate Adjustments	4,547	8,960	18,113	13,210	11,125
Miscellaneous Cash Flow Adjustments	-1	-1	1	-	-1
Net Cash Flow	93,233	-147,315	-41,153	60,854	-10,143
Free Cash Flow	502,465	157,509	134,419	291,326	226,705
Free Cash Flow Growth	219.01%	17.18%	-53.86%	28.50%	-17.70%
Free Cash Flow Margin	23.49%	8.24%	8.38%	19.18%	17.49%
Free Cash Flow Per Share	279.60	87.64	74.69	159.63	122.50
Cash Income Tax Paid	98,612	85,478	38,112	69,479	42,093
Levered Free Cash Flow	388,721	125,260	134,671	202,242	174,913
Unlevered Free Cash Flow	397,516	133,980	139,311	204,253	176,360
Change in Working Capital	-36,985	-147,747	-51,702	73,980	-10,683

Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.